The A Team
We invite you to take part in Great Strides by joining our team. We promise, you belong here! This event promises to be a fun-filled day where you can help advance the care and research needed to cure cystic fibrosis. By walking with us, you’ll enjoy not only the natural camaraderie (yes, lots of laughter!), but the important impact we are making together.
While the CF Foundation has made incredible progress, not everyone with CF can benefit from existing therapies and we still need a cure. This will require time, funding, and persistence – but with you on our team – we are ready to go the distance.
Our team is committed to providing every person with CF the opportunity to live a long, healthy life. Will you join us?
While the CF Foundation has made incredible progress, not everyone with CF can benefit from existing therapies and we still need a cure. This will require time, funding, and persistence – but with you on our team – we are ready to go the distance.
Our team is committed to providing every person with CF the opportunity to live a long, healthy life. Will you join us?
MAR
25
25
Allison graduated May 3, 2024 from University of South Carolina with a BSN in Nursing. She began her nursing career at Duke University Medical Center as a Pediatric nurse in July and LOVES it! This past year she has successfully managed completing clinicals 2-3 days a week and starting a new job working 3, 12 hour shifts(alternating day/night shifts)as well as her health and CF regimen of daily vest treatments, breathing treatments and oral medications throughout the day. Since starting Trikafta( (elexacaftor/ivacaftor/tezacaftor), a triple combination therapy available to treat patients who have at least one F508del mutation, which is estimated to represent 90% of the CF population)in September 2019, Allison has been very healthy. No hospitalizations since July 2019! Trikafta really has been a game changer for Allison and so many others fighting Cystic Fibrosis. It has been a challenging and incredible journey since diagnosis March 1, 2001, learning and seeing very encouraging advances over the last 24 years. With continued support, we are confident research will progress at a similar pace and the rarest CF gene mutations will be addressed, including Allison's.
Comments